Better performance was exhibited in patients with luminal A or B subtypes than in those with non-luminal (HER2-enriched or TNBC) subtypes with borderline significance. 3.
← all excerpts
Feasibility of Charcoal Tattooing of Cytology-Proven Metastatic Axillary Lymph Node at Diagnosis and Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients.
1
—
—